NCT01582074View on ClinicalTrials.gov

The Ultrasound Study of Tamoxifen

CompletedOBSERVATIONAL

Enrollment

247

Participants

Timeline

Start Date

July 5, 2011

Primary Completion Date

December 31, 2015

Study Completion Date

January 1, 2016

Conditions

Breast Neoplasms

Trial Locations (1)

48202

Henry Ford Health Systems, Detroit

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT01582074 - The Ultrasound Study of Tamoxifen | Biotech Hunter | Biotech Hunter